YSYu. Yu. Samokhina

Yu. Yu. Samokhina

*This is an algorithmically generated author record based on publicly available information.

Yu. Yu. Samokhina has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Independent ECG indicators of adverse outcome risk in the asymptomatic, at low risk Russian elderly working-aged population

    by G.A. Muromtseva, A.G. Soplenkova, V.A. Kutsenko, V.G. Vilkov, Yu.YU. Samohina, S.A. Maksimov, Yu.A. Balanova, S.E. Evstifeeva, A.E. Imaeva, A.V. Kapustina, et al.

    Objective. To identify independent electrocardiographic risk markers associated with all-cause and cardiovascular mortality, as well as the composite endpoint within a SCORE low-risk cohort of older working-age individuals in Russia. Materials and methods. The symptom-free cohort comprised older working-age participants (aged 40 to 64) selected from the random populations of nine regions participating in the ESSE-RF study. A total of 6.407 individuals (27.7% male) were included, all of whom had no prior history of myocardial infarction, stroke, coronary heart disease, or type 2 diabetes mellitus. Each participant had a low cardiovascular risk as determined by the SCORE scale. The study assessed the risk of both all-cause mortality (OCM) and cardiovascular mortality (CVM), as well as a composite endpoint (CEP) that included CVM cases or new incidences of myocardial infarction or stroke. The median follow-up duration was 11.6 years. Electrocardiograms (ECGs) at rest were analyzed in the standardized manner by the Minnesota Code. One-factor logistic regression was employed to identify predictive ECG metrics. Multifactorial stepwise regression was utilized to select independent high-risk ECG metrics, after excluding collinear (codependent) variables (VIF>5) from the analysis. The statistical calculations were adjusted for age and sex. Results. The analysis identified independent ECG metrics linked to adverse outcomes in the studied cohort, specifically rhythm and conduction disorders (such as complete left bundle branch block and atrial fibrillation), as well as changes in the STT period, characterized as «major ST disorders» and «minor STT disorders,» and signs of myocardial ischemia in the absence of left ventricular hypertrophy. The developed ECG models indicated that the OCM risk or CVM risk was doubled, and the CEP risk was 3.7 times higher than in the cohort without these ECG abnormalities. Within the analyzed cohort, there were identified 3—8% of individuals with increased adverse outcome risk using these ECG models. Conclusions. This study demonstrated a high predictive capability of electrocardiography in a Russian cohort of older working-age individuals with low cardiovascular risk according to the SCORE scale. The developed models are effective for predicting all-cause and cardiovascular mortality as well as the composite endpoint in the medium term. These findings provide valuable insights that can improve traditional methods of risk assessment for symptom-free populations.

  • Open Access

    Fatty liver index as a predictor of fatal and non-fatal cardiovascular events in Russians: analysis of an epidemiological cohort

    by S. E. Evstifeeva, S. A. Shalnova, V. A. Kutsenko, А. V. Kapustina, G. A. Muromtseva, Yu. A. Balanova, A. E. Imaeva, N. S. Karamnova, M. B. Kotova, S. A. Maksimov, et al.

    Aim. To study the associations of a high fatty liver index (FLI ≥60) with the risk of death and nonfatal cardiovascular events in a Russian epidemiological cohort. Material and methods. The analysis included data from ESSE-RF2 epidemiological study. FLI was calculated using the Bedogni G et al. equation (2006). A high FLI ≥60 was considered a predictor of liver steatosis. A total of 5381 individuals aged 25-64 years from 4 Russian regions (the Republic of Karelia, Krasnodar Krai, Omsk and Ryazan Oblasts) were included, of which 1672 had FLI ≥60. Fatal endpoints included all-cause (ACD) and cardiovascular death (CVD), while nonfatal endpoints included myocardial infarction (MI), cerebrovascular accident (CVA), heart failure progression (hospitalization), and revascularization. The composite endpoint (CE) included cardiovascular death or a non-fatal endpoint. Statistical analysis was performed using the R language and environment (version 4.2). The significance level for all tested hypotheses was pResults. Kaplan-Meier survival curve analysis showed that the group of patients with a FLI ≥60 had significantly worse survival outcomes compared to the group with an FLI Conclusion. In the group of individuals with a FLI ≥60, survival rates were significantly lower than in the group with a FLI <30 for all studied outcomes (ACD, CVD, and CE). In a univariate Cox regression model adjusted for region, a high FLI was associated with non-fatal CVA, ACD, CVD, and CE. However, in a multivariable model (adjusted for region, age, sex, lifestyle factors, and lipid metabolism disorders), a significant association of FLI ≥60 remained only with CE.

  • Open Access

    Association of high-sensitivity C-reactive protein with fatal and non-fatal cardiovascular events in working-age people: data from the ESSE-RF study

    by S. E. Evstifeeva, S. A. Shalnova, V. A. Kutsenko, E. B. Yarovaya, Yu A. Balanova, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, S. A. Maksimov, N. S. Karamnova, et al.

    Aim. To study the relationship of different levels of high-sensitivity C-reactive protein (hs-CRP) with cardiovascular events and assess its contribution to the development of outcomes in Russian regions.Material and methods. The work used the data from the multicenter study ESSE-RF — a representative sample of male and female population aged 25-64 years. All participants signed informed consent. The study included 10421 people (women, 6399 (61,4%)). The cohort was followed up from 2012 to 2019 (median follow-up period, 5,5 years). A hard endpoint (cardiovascular mortality and nonfatal myocardial infarction (MI)) was determined in 187 people, while a soft endpoint (nonfatal MI, stroke, revascularization, heart failure progression and cardiovascular mortality) — in 319 people.Results. The results showed that hs-CRP is significantly associated with the main risk factors (with the exception of low-density lipoproteins). At the same time, it was found that optimal hs-CRP level for predicting the risk of cardiovascular events (CVE) in Russian population is significantly lower than 3 mg/L, but higher than 1 mg/L (1,54/1,89 mg/dL for men and women, respectively). Adding hs-CRP to sex and age significantly improved risk prediction (AUC, 79,7; 95% CI, 77,8-81,7). At the same time, adding a wide list of confounders to hs-CRP, sex and age does not improve the model’s predictive value (AUC, 79,7; 78,2-82,1).Conclusion. This study for the first time showed a significant independent contribution of hs-CRP to CVEs development in the Russian population, and the addition of hs-CRP to sex and age significantly increased the predictive value of model.